WHO Highlights Need for Child-Friendly Cancer Medicines
Geneva, September Children undergoing cancer treatment can face challenges when medicines are designed primarily for adults. Large tablets, unpleasant-tasting liquids and formulations that are difficult to administer can make treatment more complicated for young patients.
The World Health Organization (WHO) is highlighting the importance of developing age-appropriate cancer medicines that are easier for children to take and allow healthcare professionals and caregivers to administer treatment more accurately.
Challenges With Adult Medicines
Many medicines used in childhood cancer care may not be available in formulations specifically designed for children. When adult formulations have to be adapted, healthcare providers may need to divide tablets, measure liquid medicines or otherwise adjust the available product.
Such approaches can create practical difficulties, particularly when precise dosing is required. The taste, texture or size of a medicine can also affect whether a child is able or willing to take it as prescribed.
For children receiving lengthy or intensive cancer treatment, making medicines easier to administer can be an important part of supportive care.
Developing More Suitable Formulations
Manufacturers are working with guidance from WHO and other health stakeholders to develop medicines that better reflect the needs of children.
Potential approaches include flexible formulations, more acceptable flavours and child-friendly dosage forms. These features can help healthcare professionals and caregivers provide medicines in ways that are more appropriate for different age groups.
Flexible formulations may also help accommodate differences in children’s ages, body sizes and treatment requirements.
Supporting Safer Treatment
Child-appropriate medicines are intended to address more than convenience. Accurate dosing is particularly important in pediatric cancer care because medicines need to be administered according to the treatment plan established by healthcare professionals.
When suitable formulations are unavailable, adapting adult medicines can introduce additional challenges in measuring or administering the required dose.
Developing medicines specifically for children can therefore support safer and more consistent treatment when used according to medical guidance.
Making Cancer Care More Child-Friendly
Cancer treatment can be physically and emotionally demanding for children and their families. Improving the way medicines are formulated and administered is one part of efforts to make pediatric cancer care more accessible and appropriate.
WHO’s work in this area emphasizes the need for pharmaceutical products that consider children’s specific requirements rather than relying exclusively on adult formulations.
The development of palatable and flexible medicines could help reduce some of the practical barriers associated with administering cancer treatment to children.
As research and pharmaceutical development continue, greater availability of age-appropriate formulations could contribute to more child-centred approaches to cancer care around the world.
